Related Experiment Videos
[Contact dermatitis caused by Septopal]
Medicina Cutanea Ibero-Latino-Americana
|January 1, 1986
Abstract:
A man affected of a femur osteomyelitis was treated with Septopal (Merck) and presented an allergic contact dermatitis on the left thigh, thorax, abdomen with bilateral oedema of eyelids and generalized pruritus. The cause was a co-polymer of methyl-methacrylate-methacrylate of the material of the small balls of Septopal, which liberates gentamycin contained inside through little pores.
Insights
Septopal treatment for femur osteomyelitis caused allergic contact dermatitis due to its methyl-methacrylate co-polymer. This material released gentamycin, leading to skin reactions and eyelid edema in the patient.
Area of Science:
- Orthopedics
- Dermatology
- Materials Science
Background:
- Femur osteomyelitis is a serious bone infection requiring effective treatment.
- Septopal, a gentamicin-releasing implant, is used for bone infections.
- Allergic reactions to medical implants can complicate treatment.
Observation:
- A patient treated for femur osteomyelitis with Septopal developed allergic contact dermatitis.
- The dermatitis manifested on the thigh, thorax, and abdomen, accompanied by eyelid edema and pruritus.
- The reaction occurred despite the gentamicin payload within the implant.
Findings:
- The allergic reaction was attributed to the methyl-methacrylate co-polymer of the Septopal implant.
- This co-polymer material leached gentamicin through micropores, triggering the contact dermatitis.
- The specific component causing the allergy was identified as the implant's polymer matrix.
Implications:
- Highlights the potential for allergic reactions to non-antibiotic components of drug-eluting implants.
- Suggests the need for careful material selection and biocompatibility testing of orthopedic implants.
- Underscores the importance of considering implant material allergies in differential diagnosis of post-operative skin reactions.